Trevor L. Brasel, PhD, M(ASCP)CM

Roles: 

Study Director, Institutional Office of Regulated Nonclinical Studies

Assistant Professor, Department of Microbiology & Immunology

Education and Certifications:

  • M(ASCP)CM [2018, Houston, TX], American Society for Clinical Pathology
  • Categorical Certification, Clinical Microbiology [2008, Galveston, TX], University of Texas Medical Branch
  • Post-doctoral Fellowship[2005, Albuquerque, NM], Lovelace Respiratory Research Institute
  • Post-doctoral Fellowship [2005, Serpukhov, Russia], Research Center for Toxicology and Hygienic Regulation of Biopreparations
  • PhD, Medical Microbiology [2004, Lubbock, TX], Texas Tech University Health Sciences Center
  • BS, Microbiology [2000, Lubbock, TX], Texas Tech University

Research Interests:

Medical countermeasure development and testing, animal model development, assay qualification/validation, regulated studies, GLP

Current Research:

Dr. Brasel’s research focuses on the strategic planning and execution of preclinical studies that evaluate medical countermeasures (vaccines and therapeutics) toward licensure.  His primary interests lie in the implementation of quality systems and regulatory processes in BSL-3 and BSL-4 laboratories to advance product development.  Current projects include vaccine and therapeutic development and testing against filoviruses, including Ebola and Marburg viruses, and SARS-CoV-2, the causative agent of COVID-19.   As a means to further advance the field of regulatory science in high biocontainment laboratories, Dr. Brasel is serving as co-Principal Investigator on a grant funded through the FDA entitled “Achieving Data Quality and Integrity in Maximum Containment Laboratories,” now in its eighth year of funding (https://www.fda.gov/emergency-preparedness-and-response/mcmi-professional-development-activities/training-course-achieving-data-quality-and-integrity-maximum-containment-laboratories).  Dr. Brasel’s ultimate goal is FDA approval of high-profile medical countermeasures specific for biodefense-related and emerging diseases.

Search PubMed Database for Publications (link): https://www.ncbi.nlm.nih.gov/pubmed/?term=brasel+t

 

Trevor BraselPhone: (409) 266-6907

Mail Route: 0610

Office: Galveston National Laboratory (GNL) 5.200U

E-mail: trbrasel@utmb.edu